The HPV, or Human papillomavirus, vaccine can cause various reactions and injuries including shoulder injuries, allergic reaction, seizures, and other adverse effects. If you have suffered an adverse reaction or injury after receiving the HPV vaccine, you may be entitled to compensation from a federal fund called the National Vaccine Injury Compensation Trust Fund.
The HPV vaccine is administered to prevent human (“HPV”), which is a sexually transmitted disease that may lead to cervical cancer. HPV is the most common sexually transmitted infection in adults. Three Food and Drug Administration ("FDA") approved HPV vaccines are currently on the market: Gardasil, Gardasil 9, and Cervarix.
Throughout the United States, the HPV vaccine is highly recommended for young women at the ages of 11 or 12. The vaccine is usually given in a three dose series. The first dose of HPV vaccine is generally given at 11 or 12 years old, with the second dose being 1 or 2 months later, and the final dose 6 months after the first vaccination.
The intended results of the vaccine aim to protect young women against CIN2+ and CIN3+ (cervical intraepithelial neoplasia). CIN2+ and CIN3+ is the abnormal growth of cells across the surface of the cervix, which is a possible precursor to cervical cancer.
The HPV vaccine may cause severe allergic reactions, pain in the injection site, joint pain, fatigue, and other conditions. There have been more severe reactions reported from the HPV vaccination.
As of August 2018, a recent medical study published by the Lancet Child & Adolescent Health Journal revealed positive results about a new dosage of the HPV vaccine. The quadrivalent HPV dosage is a ‘catch-up’ vaccine for young women ages 14 through 20 who may have missed an earlier opportunity for the vaccine at an earlier age. Results revealed that women aged 14 through 20 who had received all three doses of the quadrivalent HPV vaccine had greater protection against CIN2+ and CIN3+. For a more detailed view on this story, take a look at our blog about it here on August 9th, 2018.
Going forward, the Lancet Child & Adolescent Health Journal noted that future research still needs to be done on the effectiveness of the quadrivalent HPV vaccine for women ages 21 through 26.
The HPV Bivalent Cervarix vaccine, made by GlaxoSmithKline Biologicals, is made up of the following list of ingredients (not in order of quantity):
The HPV Quadrivalent Gardasil vaccine, made by Merck & Co., Inc., is made up of the following list of ingredients (not in order of quantity):
The HPV 9-valent Gardasil 9 vaccine, made by Merck & Co., Inc., is made up of the following list of ingredients (not in order of quantity):
If you suffered an adverse reaction, illness, or injury after receiving the HPV vaccine, you may qualify for compensation from a government fund called the National Vaccine Injury Compensation Trust Fund. Not only is the phone call free, but our representation comes at no cost to you. To see a list of our notable vaccine injury settlements, click on the graphic below for more detailed information.